Valuation DHG Pharmaceutical

Stocks

DHG

VN000000DHG0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 25/08/2026			5-day change	1st Jan Change
95,600.00 ^VND	-0.52%		+2.25%	-6.55%

07-20	DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-14	Large Enterprise Tax Sub-Department Imposes Administrative Penalty on DHG Pharmaceutical Joint Stock Company	CI

Company Valuation: DHG Pharmaceutical

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	14,774,306	11,100,341	13,597,591	13,584,517	13,375,323	12,551,623	-	-
Change	-	-24.87%	22.5%	-0.1%	-1.54%	-6.16%	-	-
Enterprise Value (EV) ¹	12,828,324	11,100,341	11,845,622	11,426,573	11,221,427	10,689,123	10,693,823	10,700,823
Change	-	-13.47%	6.71%	-3.54%	-1.8%	-4.74%	0.04%	0.07%
P/E	19.8x	11.6x	13.4x	18x	15.4x	13.5x	12.8x	12x
PBR	3.9x	2.59x	-	-	-	-	-	-
PEG	-	0.4x	2.1x	-0.7x	1x	1.97x	2.16x	1.82x
Capitalization / Revenue	3.69x	2.37x	2.71x	2.78x	2.54x	2.31x	2.21x	2.11x
EV / Revenue	3.2x	2.37x	2.36x	2.34x	2.13x	1.97x	1.88x	1.8x
EV / EBITDA	13.6x	9.59x	10.4x	10.5x	10.2x	9.25x	8.56x	8.01x
EV / EBIT	14.5x	9.98x	11.2x	12.4x	11.4x	10.2x	9.4x	8.77x
EV / FCF	30x	16.6x	-48.1x	9.3x	9.48x	21.9x	13.1x	12.6x
FCF Yield	3.34%	6.01%	-2.08%	10.8%	10.5%	4.57%	7.61%	7.91%
Dividend per Share ²	4,000	-	-	10,000	-	7,000	7,200	7,500
Rate of return	3.54%	-	-	9.62%	-	7.29%	7.5%	7.81%
EPS ²	5,720	7,318	7,786	5,763	6,644	7,100	7,521	8,016
Distribution rate	69.9%	-	-	174%	-	98.6%	95.7%	93.6%
Net sales ¹	4,003,170	4,676,016	5,015,395	4,884,868	5,266,963	5,435,000	5,690,600	5,958,700
EBITDA ¹	944,647	1,157,079	1,140,985	1,089,971	1,105,507	1,155,200	1,248,900	1,335,900
EBIT ¹	884,537	1,112,058	1,053,025	920,276	986,499	1,047,900	1,137,100	1,219,600
Net income ¹	777,220	988,455	1,051,490	778,920	897,576	928,400	983,400	1,048,100
Net Debt ¹	-1,945,982	-	-1,751,969	-2,157,944	-2,153,896	-1,862,500	-1,857,800	-1,850,800
Reference price ²	113,000.00	84,900.00	104,000.00	103,900.00	102,300.00	96,000.00	96,000.00	96,000.00
Nbr of stocks (in thousands)	130,746	130,746	130,746	130,746	130,746	130,746	-	-
Announcement Date	1/20/22 A	1/19/23 A	1/19/24 A	1/20/25 A	1/20/26 A	-	-	-

¹VND in Million²VND

Estimates

P/E, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DHG PHARMACEUTICAL	13.52x	1.97x	9.25x	7.29%	481M
ELI LILLY AND COMPANY	33.86x	12.29x	24.9x	0.58%	1,060B
JOHNSON & JOHNSON	30.03x	-	-	1.99%	651B
ABBVIE INC.	33.56x	7.77x	16.15x	2.61%	465B
ROCHE HOLDING AG	20.52x	4.87x	12.06x	2.71%	365B
NOVARTIS AG	22.43x	5.77x	14.31x	2.77%	300B
ASTRAZENECA PLC	21.39x	4.38x	12.52x	2.01%	258B
AMGEN INC.	27.85x	7.18x	12.75x	2.29%	238B
NOVO NORDISK A/S	13.86x	4.91x	10.27x	3.71%	210B
GILEAD SCIENCES, INC.	-45.25x	6.53x	25.49x	2.23%	184B
Average	17.18x	6.19x	15.30x	2.82%	373.09B
Weighted average by Cap.	24.66x	8.19x	18.09x	1.93%